These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35524342)

  • 1. Immune checkpoints in T cells during oncogenic γ-herpesvirus infections.
    Münz C
    J Med Virol; 2023 Jan; 95(1):e27840. PubMed ID: 35524342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers-A Focus on EBV and KSHV Life Cycles and Carcinogenesis.
    Hassan STS; Šudomová M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancers associated with human gammaherpesviruses.
    Wen KW; Wang L; Menke JR; Damania B
    FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
    Böni M; Rieble L; Münz C
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.
    Damania B; Münz C
    FEMS Microbiol Rev; 2019 Mar; 43(2):181-192. PubMed ID: 30649299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report.
    Julius P; Kang G; Siyumbwa S; Musumali J; Tso FY; Ngalamika O; Kaile T; Maate F; Moonga P; West JT; Angeletti P; Wood C
    Front Cell Infect Microbiol; 2023; 13():1270935. PubMed ID: 37928187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell responses to human oncogenic γ-herpesvirus infections.
    Münz C
    Semin Immunol; 2022 Mar; 60():101652. PubMed ID: 36162228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK4/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules.
    Wu Y; Shrestha P; Heape NM; Yarchoan R
    J Transl Med; 2022 May; 20(1):217. PubMed ID: 35562811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.
    Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H
    J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment Conditioning by Abortive Lytic Replication of Oncogenic γ-Herpesviruses.
    Münz C
    Adv Exp Med Biol; 2020; 1225():127-135. PubMed ID: 32030652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.
    McHugh D; Caduff N; Murer A; Engelmann C; Deng Y; Zdimerova H; Zens K; Chijioke O; Münz C
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180296. PubMed ID: 30955487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology Frontiers in γ-Herpesviruses Treatments.
    Granato M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections.
    Münz C
    Front Immunol; 2020; 11():581419. PubMed ID: 33013936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections.
    Münz C
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-herpesvirus neoplasia: a growing role for COX-2.
    Shelby BD; Nelson A; Morris C
    Microsc Res Tech; 2005 Nov; 68(3-4):120-9. PubMed ID: 16276519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.
    Lurain KA; Ramaswami R; Krug LT; Whitby D; Ziegelbauer JM; Wang H-W; Yarchoan R
    Clin Microbiol Rev; 2024 Sep; 37(3):e0002223. PubMed ID: 38899877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EBV/KSHV co-infection: an effective partnership].
    Gruffat H; Manet E
    Med Sci (Paris); 2018 Jan; 34(1):79-82. PubMed ID: 29384100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
    Katano H
    Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.